X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (907) 907
Book Chapter (37) 37
Newspaper Article (11) 11
Web Resource (10) 10
Patent (7) 7
Book / eBook (5) 5
Conference Proceeding (2) 2
Publication (2) 2
Book Review (1) 1
Magazine Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (379) 379
gastroenterology & hepatology (302) 302
female (207) 207
male (206) 206
middle aged (179) 179
gastroenterology and hepatology (158) 158
adult (134) 134
cirrhosis (129) 129
liver diseases (128) 128
fibrosis (97) 97
fatty liver (91) 91
liver (87) 87
nonalcoholic steatohepatitis (85) 85
aged (71) 71
animals (68) 68
fatty liver-disease (68) 68
insulin-resistance (68) 68
liver - pathology (68) 68
liver cirrhosis (65) 65
biopsy (61) 61
care and treatment (60) 60
liver cirrhosis - complications (59) 59
prevalence (58) 58
risk factors (57) 57
abridged index medicus (56) 56
non-alcoholic fatty liver disease (54) 54
insulin resistance (53) 53
metabolic syndrome (53) 53
analysis (51) 51
mortality (51) 51
nonalcoholic fatty liver disease (50) 50
treatment outcome (50) 50
prospective studies (49) 49
steatosis (49) 49
transplantation (48) 48
natural-history (47) 47
steatohepatitis (46) 46
clinical trials (44) 44
disease progression (44) 44
obesity (44) 44
diagnosis (42) 42
nafld (42) 42
severity of illness index (40) 40
surgery (40) 40
liver transplantation (38) 38
inflammation (37) 37
hepatology (35) 35
united-states (35) 35
fatty liver - pathology (34) 34
hepatic steatosis (34) 34
mice (33) 33
metabolism (32) 32
retrospective studies (32) 32
disease (31) 31
health aspects (31) 31
hepatitis (31) 31
liver - metabolism (31) 31
liver cirrhosis - pathology (31) 31
biomarkers (30) 30
digestive system diseases (30) 30
fatty liver - metabolism (30) 30
association (29) 29
alanine transaminase - blood (28) 28
patients (28) 28
prognosis (28) 28
diabetes (27) 27
hepatic encephalopathy (27) 27
pharmacology & pharmacy (27) 27
risk (27) 27
nash (26) 26
expression (25) 25
oxidative stress (25) 25
research (25) 25
adolescent (24) 24
biochemistry & molecular biology (24) 24
medicine & public health (24) 24
non-alcoholic fatty liver disease - drug therapy (24) 24
rats (24) 24
time factors (24) 24
vitamin-e (24) 24
apoptosis (23) 23
endocrinology & metabolism (23) 23
hepatocellular carcinoma (23) 23
liver cirrhosis - diagnosis (23) 23
non-alcoholic fatty liver disease - complications (23) 23
non-alcoholic fatty liver disease - pathology (23) 23
portal hypertension (23) 23
biomarkers - blood (22) 22
fatty liver - diagnosis (22) 22
non-alcoholic steatohepatitis (22) 22
pathogenesis (22) 22
diabetes mellitus (21) 21
double-blind method (21) 21
hepatocellular-carcinoma (21) 21
hypertension (21) 21
liver cirrhosis - etiology (21) 21
medicine (21) 21
medicine, general & internal (21) 21
non-alcoholic fatty liver disease - diagnosis (21) 21
nutritional and metabolic diseases (21) 21
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9972, pp. 956 - 965
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2002, Volume 123, Issue 5, pp. 1705 - 1725
Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of conditions characterized histologically by mainly macrovesicular hepatic steatosis and occurs... 
Diagnosis, Differential | Liver - pathology | Fatty Liver - diagnosis | Prevalence | Biopsy | Fatty Liver - physiopathology | Humans | Fatty Liver - therapy | Alcoholism - complications | Fatty Liver - etiology | Incidence
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2018, Volume 67, Issue 1, pp. 123 - 133
Journal Article
Journal Article
Liver international, ISSN 1478-3223, 2017, Volume 37, Issue S1, pp. 97 - 103
The hallmark of non‐alcoholic fatty liver disease (NAFLD) is excessive fatty accumulation in the hepatocytes, which may be an isolated event (non‐alcoholic... 
non‐alcoholic steatohepatitis (NASH) | peroxisome proliferator‐activator receptor (PPAR) agonists | farnesoid X receptor (FXR) | non‐alcoholic fatty liver disease (NAFLD) | ROS (reactive oxygen species) | glucagon‐like peptide (GLP‐1) agonist | non-alcoholic fatty liver disease (NAFLD) | glucagon-like peptide (GLP-1) agonist | peroxisome proliferator-activator receptor (PPAR) agonists | non-alcoholic steatohepatitis (NASH) | VITAMIN-E | ACID | RANDOMIZED-TRIALS | AMERICAN ASSOCIATION | FATTY LIVER-DISEASE | WEIGHT-LOSS | GLUCAGON-LIKE PEPTIDE-1 | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | PENTOXIFYLLINE | Hypoglycemic Agents - therapeutic use | Liver Cirrhosis - etiology | Liver - pathology | Liver Transplantation | Humans | Risk Factors | Non-alcoholic Fatty Liver Disease - therapy | Disease Progression | Randomized Controlled Trials as Topic | Liver Neoplasms - etiology | Non-alcoholic Fatty Liver Disease - complications | Thiazolidinediones - therapeutic use | Exercise | Diet | Fibrosis | Vitamin E - therapeutic use | Carcinoma, Hepatocellular - etiology | Liver diseases | Syngeneic grafts | Pathogenesis | Liver | Pioglitazone | Viruses | Hepatocellular carcinoma | Transplantation | Infections | Steatosis | Hepatitis | Cirrhosis | Fatty liver | Cell injury | Hepatocytes | Vitamin E | Hepatitis C virus | Hepatitis C | Tocopherol | Liver transplantation | Nonalcoholic fatty liver disease (NAFLD) | Farnesoid X receptor (FXR) | Glucagon-like peptide (GLP-1) agonist | Peroxisome proliferator-activator receptor (PPAR) agonists | Nonalcoholic steatohepatitis (NASH)
Journal Article
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5053, 2013, Volume 10, Issue 11, pp. 686 - 690
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 7, pp. 539 - 549
Journal Article
Journal Article